Co-expression of the C-terminal domain of Yersinia enterocolitica invasin enhances the efficacy of classical swine-fever-vectored vaccine based on human adenovirus

Journal of Biosciences
Helin LiYanming Zhang

Abstract

The use of adenovirus vector-based vaccines is a promising approach for generating antigen-specific immune responses. Improving vaccine potency is necessary in other approaches to address their inadequate protection for the majority of infectious diseases. This study is the first to reconstruct a recombinant replication-defective human adenovirus co-expressing E2 and invasin C-terminal (InvC) glycoproteins (rAd-E2-InvC). rAd-E2-InvC with 2 x 10(6) TCID50 was intramuscularly administered two times to CSFV-free pigs at 14 day intervals. No adverse clinical reactions were observed in any of the pigs after the vaccination. The CSFV E2-specific antibody titer was significantly higher in the rAd-E2-InvC group than that in the rAdV-E2 group as measured by NPLA and blocking ELISA. Pigs immunized with rAd-E2-InvC were completely protected against lethal challenge. Neither CSFV RNA nor pathological changes were detected in the tissues after CSFV challenge. These results demonstrate that rAd-E2-InvC could be an alternative to the existing CSF vaccine. Moreover, InvC that acts as an adjuvant could enhance the immunogenicity of rAdV-E2 and induce high CSFV E2-specific antibody titer and protection level.

References

Jun 1, 1994·Journal of Virology·P A van RijnR J Moormann
Jan 1, 1996·Advances in Virus Research·G Meyers, H J Thiel
Apr 28, 2000·Veterinary Microbiology·V Moennig
Aug 6, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·R SchulteI B Autenrieth
Mar 6, 2003·The Veterinary Journal·V MoennigI Greiser-Wilke
Feb 8, 2005·Current Opinion in Microbiology·Ka-Wing Wong, Ralph R Isberg
Apr 7, 2005·Nature Medicine·Achal PashineJeffrey B Ulmer
Dec 7, 2005·Journal of Molecular Biology·J Christopher AndersonChristopher A Voigt
Apr 4, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Rebecca J Critchley-ThorneGeorges Vassaux
Aug 29, 2006·Vaccine·Xiao-Nan Dong, Ying-Hua Chen
Sep 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Toshihiko SuzukiChihiro Sasakawa
Jan 24, 2007·Vaccine·Martin BeerKlaus Depner
Aug 19, 2007·International Journal of Medical Microbiology : IJMM·Stella E Autenrieth, Ingo B Autenrieth
Sep 24, 2008·Vaccine·Brice BarefootElizabeth Ramsburg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.